Clinical Trial Update: CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery [NA]

View source ↗

Summary

This clinical trial update reports that the CytoSorb device was studied in elective cardiac surgery for reducing free hemoglobin and acute kidney injury, with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• CytoSorb

Snippet

Sponsor: CytoSorbents, Inc | Conditions: Elective Cardiac Surgery | NA | Status: TERMINATED | Results posted: 2024-12-04